NCT05680376 is a clinical trial in Autoimmune Thyroiditis, sponsored by Zonguldak Bulent Ecevit University.

Who is sponsoring NCT05680376?

NCT05680376 is sponsored by Zonguldak Bulent Ecevit University.

What condition does NCT05680376 study?

NCT05680376 studies Autoimmune Thyroiditis, Recurrent Miscarriage.

Is NCT05680376 still recruiting?

NCT05680376 is currently completed. Last updated 11 January 2023.

Last reviewed 2023-01-11 · How we verify

NCT05680376

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Thyroid Hormone Values and Anti-thyroid Peroxidase Antibody Positivity in Recurrent Pregnancy Loss

Completed Last updated 11 January 2023

What this trial tests

trial in Autoimmune Thyroiditis in 103 participants. Completed in 1 October 2022.

Timeline

1 January 2018

Primary endpoint
1 October 2022

1 October 2022

Quick facts

Lead sponsor	Zonguldak Bulent Ecevit University
Status	Completed
Study type	OBSERVATIONAL
Enrollment	103
Start date	1 January 2018
Primary completion	1 October 2022
Estimated completion	1 October 2022
Sites	1 location across Turkey (Türkiye)

Conditions studied

Autoimmune Thyroiditis — all drugs for Autoimmune Thyroiditis →
Recurrent Miscarriage — all drugs for Recurrent Miscarriage →

Sponsor

Zonguldak Bulent Ecevit University

Who can join

Adults 18 to 45, female only, with Autoimmune Thyroiditis or Recurrent Miscarriage. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The aim of this study is to compare the thyroid hormone values and anti-thyroid peroxidase (anti-TPO) levels of women with a diagnosis of recurrent pregnancy loss (RPL) and healthy pregnancies. The primary objective is to find out the relationship between recurrent pregnancy loss with thyroid hormone levels and anti-TPO positivity.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

Medical Applications of Molecular Biotechnologies in the Context of Hashimoto's Thyroiditis.
Trovato M, Valenti A. · · 2023 · cited 1× · PMID 37371008 · DOI 10.3390/diagnostics13122114

Verify or expand the search:

Other Zonguldak Bulent Ecevit University trials

Trials by the same sponsor.

NCT07235735 — The Effect of Laughter Yoga on Individual and Organizational Outcomes in Nurse Managers · NA · not yet recruiting
NCT07246720 — IPP-PSP Block vs. SPSIPB in Breast Surgery · NA · not yet recruiting
NCT07585903 — The Effect of Family-Centered Care Practices In Pediatric Intensive Care Unit · NA · completed
NCT07382895 — The Relationship Between the ASA Score Determined by Operating Room Nurses and Intubation Duration · completed
NCT06948383 — SPSIPB vs. SAPB in Breast Surgery · NA · active not recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05680376 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Zonguldak Bulent Ecevit University
Last refreshed: 11 January 2023

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05680376.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing